NCT04977024 2026-02-11SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood CancerGeoVax, Inc.Phase 2 Active not recruiting63 enrolled
NCT05438498 2023-09-08Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2MediMergent, LLCPhase 3 Terminated550 enrolled
NCT04419623 2021-05-12A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With CancerTelios Pharma, Inc.Phase 1 Completed7 enrolled